Skip to main content
MedPathMedPath Home
Clinical Trials/NL-OMON35994
NL-OMON35994
Completed
Not Applicable

DNA testing for BRCA1/2 in breast cancer patients prior to genetic counseling: DNA-direct - DNA-direct

niversitair Medisch Centrum Sint Radboud0 sites150 target enrollmentTBD
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsBRCA gene mutationhereditary breast cancer1008362410006291

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
BRCA gene mutation
Sponsor
niversitair Medisch Centrum Sint Radboud
Enrollment
150
Status
Completed
Last Updated
last year
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
last year
Study Type
Observational non invasive

Investigators

Sponsor
niversitair Medisch Centrum Sint Radboud

Eligibility Criteria

Inclusion Criteria

  • •All female breast cancer patients (recently diagnosed or in the past) referred to Human Genetics of the Radboud University Medical Centre Nijmegen for genetic counseling.

Exclusion Criteria

  • •For the DNA\-direct procedure: problems with (large amounts of) written Dutch text, current psychological / psychiatric treatment (including medication), problems with family communication about cancer as estimated by the patient.

Outcomes

Primary Outcomes

Not specified

Similar Trials

Recruiting
Not Applicable
Genetic testing in breast cancer patients based on a home information package: DNA-direct.BRCA1/2, breast cancer, borstkanker, hereditary breast cancer, erfelijke borstkanker
NL-OMON22096MC St Radboud / Radboud University Medical Center (Nijmegen)150
Completed
Not Applicable
Can a peer support program for women with an altered cancer gene reduce distress?Psychosocial effects of testing positive for a mutation of the BRCA1/2 geneCancer - Ovarian and primary peritonealMental Health - AnxietyCancer - Breast
ACTRN12608000343303The Cancer Council Victoria337
Completed
Not Applicable
Testing BRCA 1/2 Mutation Using Next Generation SequencingBreast NeoplasmsBreast Cancer
NCT02151747Severance Hospital12
Recruiting
Not Applicable
COLLECTION OF DNA AND RNA FROM BREAST CANCER PATIENTSbreast cancer10006291
NL-OMON34596niversitair Medisch Centrum Sint Radboud150
Unknown
Not Applicable
Studying Breast Cancer Risk in Women Who Are BRCA1/BRCA2 Mutation Carriersbrca1 Mutation Carrierbrca2 Mutation CarrierBreast Cancer
NCT00897455Gynecologic Oncology Group10,000